Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company utilizing generative AI for therapeutic development, announced its participation in four upcoming investor conferences in March 2026. The company will engage in fireside chats and host one-on-one meetings with investors at events including the TD Cowen 46th Annual Health Care Conference and Leerink Partners 2026 Global Healthcare Conference. Webcasts of the fireside chats will be available on Absci’s investor relations website.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Absci to Participate in Upcoming Investor Conferences
Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company utilizing generative AI for therapeutic development, announced its participation in four upcoming investor conferences in March 2026. The company will engage in fireside chats and host one-on-one meetings with investors at events including the TD Cowen 46th Annual Health Care Conference and Leerink Partners 2026 Global Healthcare Conference. Webcasts of the fireside chats will be available on Absci’s investor relations website.